Dermatology
Conference Coverage
First JAK inhibitor in psoriatic arthritis achieves results similar to adalimumab
WASHINGTON – Tofacitinib demonstrated efficacy comparable to adalimumab in patients with active psoriatic arthritis and an inadequate response to...
From the Journals
Topical tofacitinib shows promise in atopic dermatitis
Topical tofacitinib showed significant improvements across all endpoints and for pruritus at week 4, compared with vehicle, results of a phase IIa...
Conference Coverage
Include quality of life measures in evaluating treatment success of psoriasis
No matter what the disease, physician judgment of disease severity correlates poorly with the patient’s quality of life, Dr. Joel Gelfand said...
Conference Coverage
Study offers reassuring data on certolizumab use in pregnancy
VIENNA – Consider off-label certolizumab in women with psoriasis who need a biologic and are pregnant or planning to become so.
Conference Coverage
Bioactive lipid shows promise in atopic dermatitis
VIENNA – The bioactive lipid known as DGLA showed promise as a novel oral therapy for moderate-to-severe atopic dermatitis in a phase IIa study....
Conference Coverage
Caution is key when prescribing spironolactone for adult acne
NEWPORT BEACH, CALIF. – While off-label use of spironolactone for treatment of acne is quite common, it should be prescribed with special caution...
Conference Coverage
FDA’s Woodcock: Give biosimilars a chance
BOSTON – Biosimilar drugs are not identical twins of original biologic agents, but there are very strong family ties, and the newcomer is expected...
Conference Coverage
Topical crisaborole boosts quality of life in atopic dermatitis
VIENNA – Topical crisaborole 2% ointment twice a day was consistently associated with clinically meaningful quality of life improvement scores on...
From the Journals
PsA bone loss measurement: A surrogate for radiographic progression?
An advanced computer assisted digital x-ray radiogrammetry technique that measures bone thickness has the potential to be a surrogate marker of...
Feature
CMS offering educational webinars on MACRA
The Centers for Medicare & Medicaid Services is offering a pair of webinars aimed at helping physicians navigate the new regulation that...
Conference Coverage
Tildrakizumab for psoriasis scores high marks in phase III
VIENNA – Tildrakizumab, a novel biologic for moderate to severe psoriasis, showed favorable efficacy and safety outcomes in two pivotal phase III...